Increasing collaboration on substance use disorder research with primary care practices through the National Drug Abuse Treatment Clinical Trials Network
Supporting Files
-
3 2020
-
File Language:
English
Details
-
Alternative Title:J Subst Abuse Treat
-
Personal Author:
-
Description:Background:
The National Drug Abuse Treatment Clinical Trials Network (CTN) called for its national nodes to promote the translation of evidence-based interventions from substance use disorder (SUD) research into clinical practices. This collaborative demonstration project engaged CTN-affiliated practice-based research networks (PBRNs) in research that describes aspects of opioid prescribing in primary care.
Methods:
Six PBRNs queried electronic health records from a convenience sample of 134 practices (84 participants) to identify the percent of adult patients with an office visit who were prescribed an opioid medication from October 1, 2015, to September 30, 2016, and, of those, the percent also prescribed a sedative in that year. Seven PBRNs sent an e-mail survey to a convenience sample of 108 practices (58 participants) about their opioid management policies and procedures during the project year.
Results:
Of 561,017 adult patients with a visit to one of the 84 clinics in the project year, 22.9% (PBRN range 3.1%–25.4%) were prescribed opioid medications, and 52.1% (PBRN range 8.5%–60.6%) of those were prescribed a sedative in the same year. Of the 58 practices returning a survey (45.3% response rate), 98.1% had formal written treatment agreements for chronic opioid therapy, 68.5% had written opioid prescribing policies, and 43.4% provided reports to providers with feedback on opioid management. Only 24.1% were providing buprenorphine for OUD.
Conclusion:
CTN-affiliated PBRNs demonstrated their ability to collaborate on a project related to opioid management; results highlight the important role for PBRNs in OUD treatment, research, and the need for interventions and additional policies addressing opioid prescribing in primary care practice.
-
Subjects:
-
Source:J Subst Abuse Treat. 112 Suppl:34-40
-
Pubmed ID:32220408
-
Pubmed Central ID:PMC7513836
-
Document Type:
-
Funding:UG1 DA015815/DA/NIDA NIH HHSUnited States/ ; UL1 TR002369/TR/NCATS NIH HHSUnited States/ ; UL1 TR002489/TR/NCATS NIH HHSUnited States/ ; UG1 DA013714/DA/NIDA NIH HHSUnited States/ ; UL1 TR001086/TR/NCATS NIH HHSUnited States/ ; UL1 TR002553/TR/NCATS NIH HHSUnited States/ ; UG1 DA013732/DA/NIDA NIH HHSUnited States/ ; UG1 DA040317/DA/NIDA NIH HHSUnited States/ ; R01 CE003008/CE/NCIPC CDC HHSUnited States/ ; UG1 DA040309/DA/NIDA NIH HHSUnited States/ ; UL1 TR001425/TR/NCATS NIH HHSUnited States/ ; UL1 TR002319/TR/NCATS NIH HHSUnited States/
-
Collection(s):
-
Main Document Checksum:urn:sha256:38178364d84767bbc1eceac3385bc01db952c92b51061c2374d4c9a8f9f80ad4
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access